Close

Gemphire Therapeutics (GEMP) Says First Patients Enrolled in ROYAL-1 Trial for Hypercholesterolemia

Go back to Gemphire Therapeutics (GEMP) Says First Patients Enrolled in ROYAL-1 Trial for Hypercholesterolemia
(NASDAQ: GEMP) Delayed: 0.30 --0 (-0%)
Previous Close $0.30    52 Week High $13.98 
Open $58.27    52 Week Low $8.50 
Day High $0.30    P/E N/A 
Day Low $0.30    EPS $0.00 
Volume 6,852